Podiatrists in Seymour, IN Accepting Medicare
6 Podiatrists found. Showing 1 - 6
 Dr. Wendy Goldstein, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-524-3311 Fax: 812-524-3310 |
 Comprehensive Foot & Ankle Center Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1239 E 4th Street Rd, Seymour, IN 47274 Phone: 812-524-3338 Fax: 812-524-3337 |
 Walter G Warren, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1239 E 4th St Rd, Seymour, IN 47274 Phone: 812-524-3338 Fax: 812-524-3337 |
Dr. Evan Ryan Aldridge, DPM Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-524-3311 Fax: 812-524-3310 |
Upperline Healthcare Pc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1239 E 4th Street Rd, Seymour, IN 47274 Phone: 317-773-7787 |
Dr. Jason Boyd Woods, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-524-3311 Fax: 812-524-3310 |
News Archive
Single-dose Israeli vaccine candidate protective against SARS-CoV-2
Now, a new Israeli study published on the preprint server bioRxiv in June 2020 reports a new recombinant vaccine expressing the S or spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be highly protective with a single dose in an animal model. This could be a gamechanger in the fight to contain the outbreak.
Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands
Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.
New study opens door to preventative treatments for congenital diaphragmatic hernia
Congenital diaphragmatic hernia (CDH) is not as well known as muscular dystrophy and cystic fibrosis, but like them it is a life-threatening birth defect, and is just as common. Occurring in one in 3,000 births, CDH causes the guts and liver to protrude through a defective diaphragm and into the chest cavity, where they interfere with the lungs.
Micromet receives FDA feedback on blinatumomab registration for R/R ALL
Micromet, Inc. today outlined a clinical development plan intended to support U.S. registration of its lead product candidate blinatumomab in patients with B-precursor relapsed/refractory (r/r) acute lymphoblastic leukemia.
› Verified 9 days ago
Physical Therapists
Optometrists
Chiropractors
Podiatrists
Occupational Therapists
Audiologists
Speech-Language Pathologists